Medscape (7/5, Busko, Subscription Publication) reports that researchers found that “after almost a decade of testosterone injections every 3 months, 22% of men with type 2 diabetes and hypogonadism had diabetes remission, in unexpected findings from a small registry study that was only designed to assess a new preparation of the hormone.” The findings were presented at the American Diabetes Association 2018 Scientific Sessions.
No comments:
Post a Comment